Overview
India's biopharmaceutical industry is at the cusp of a transformation driven by technology, and a renewed focus on innovation. To sustain and accelerate this growth, cross-sectoral collaboration is the key.
Biopharma Synergy: Connecting Innovation and Growth is a high-impact, curated platform that brings together leaders from biopharma, biotech, digital health, manufacturing, to explore how advanced technologies such as AI/ML, next-gen biomanufacturing, and regulatory framework can shape the future of healthcare and life sciences in India.
With the BioE3 Policy opening new doors for biomanufacturing, and digital innovation becoming core to R&D, this event will spotlight the most pressing challenges, pioneering solutions, and opportunities for synergy across the biopharma value chain. Whether you're steering R&D, leading digital transformation, this platform offers unparalleled insights, real-world case studies, and collaboration opportunities to keep you at the forefront of industry evolution. This premier gathering is a strategic convergence of visionaries, scientists, technologists, and business leaders shaping the future of biopharmaceutical innovation.
Why Attend? Highlights
Gain exclusive insights into AI/ML applications across drug discovery, trials, and biologics.
Gain exclusive insights into AI/ML applications across drug discovery, trials, and biologics.
Gain exclusive insights into AI/ML applications across drug discovery, trials, and biologics.
Learn how the BioE3 policy is shaping India’s biomanufacturing roadmap.
Gain exclusive insights into AI/ML applications across drug discovery, trials, and biologics.
Gain exclusive insights into AI/ML applications across drug discovery, trials, and biologics.
Discover funding and partnership opportunities to accelerate innovation.
Be part of solution-driven discussions on sustainability, scale-up, and digital transformation.
Be part of solution-driven discussions on sustainability, scale-up, and digital transformation.
Be part of solution-driven discussions on sustainability, scale-up, and digital transformation.
Be part of solution-driven discussions on sustainability, scale-up, and digital transformation.
Be part of solution-driven discussions on sustainability, scale-up, and digital transformation.
Who Should Attend?
Esteemed Speakers
Dr. Ashish Tejam
Dr. Kasinath Viswanathan
Mr. Naresh Kumar Gaur
Vice President, India
Life Sciences Innovations Group (LSIG), Danaher India
Mr. Naresh Kumar Gaur
Dr. Kasinath Viswanathan
Mr. Naresh Kumar Gaur
EVP,
Stallion Labs Pvt. Ltd.
Dr. Kasinath Viswanathan
Dr. Kasinath Viswanathan
Dr. Kasinath Viswanathan
PhD, Head, In Vitro Biology, Drug Discovery Research,
Zydus Research Centre
Mr. Dhawal Upadhyay
Dr. Kasinath Viswanathan
Dr. Kasinath Viswanathan
Senior General Manager – Global Program Management, Intas Pharmaceuticals (Biopharma Division)
Mr. Mukesh Mahajan
Dr. Shrinivas Savale
Mr. Mukesh Mahajan
Director,
Kashiv Biosciences
Dr. Ravi Krovidi
Dr. Shrinivas Savale
Mr. Mukesh Mahajan
Founder and CEO,
Protein Advanced Analytics Pvt Ltd
Mr. Ashish Gupta
Dr. Shrinivas Savale
Dr. Shrinivas Savale
Founder & CEO,
Ortiv-Q3 Research Pvt. Ltd.
Dr. Shrinivas Savale
Dr. Shrinivas Savale
Dr. Shrinivas Savale
CEO
AIC-LMCP Foundation
Mr. Chaitanya Gundu
Mr. Radhakrishnan Srinivas
Dr. Arani Chatterjee
Country Leader, Sales & Marketing – India & SWA, Beckman Coulter Life Sciences
Dr. Arani Chatterjee
Mr. Radhakrishnan Srinivas
Dr. Arani Chatterjee
President, CRO
Cadila Pharmaceuticals Limited
Ms. Bhaswati Chatterjee
Mr. Radhakrishnan Srinivas
Mr. Radhakrishnan Srinivas
General Manager,
Intas pharmaceutical
Mr. Radhakrishnan Srinivas
Mr. Radhakrishnan Srinivas
Mr. Radhakrishnan Srinivas
Business Manager,
Beckman Coulter Life Sciences
Ms. Divya Unnikrishnan
Ms. Divya Unnikrishnan
Ms. Divya Unnikrishnan
Cell Culture Product Manager – India, Cytiva
Dr. Anirban Mudi
Ms. Divya Unnikrishnan
Ms. Divya Unnikrishnan
Lead Platform Product Manager, Next Gen and AI, IDBS
